HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-OCT-14 4WO5 TITLE CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 444-723; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 6 HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5[ALPHA]; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS KINASE, MONOMER, INHIBITOR, COMPLEX, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.CRITTON REVDAT 4 27-SEP-23 4WO5 1 SOURCE REMARK REVDAT 3 14-JAN-15 4WO5 1 JRNL REVDAT 2 17-DEC-14 4WO5 1 JRNL REVDAT 1 03-DEC-14 4WO5 0 JRNL AUTH N.THEVAKUMARAN,H.LAVOIE,D.A.CRITTON,A.TEBBEN,A.MARINIER, JRNL AUTH 2 F.SICHERI,M.THERRIEN JRNL TITL CRYSTAL STRUCTURE OF A BRAF KINASE DOMAIN MONOMER EXPLAINS JRNL TITL 2 BASIS FOR ALLOSTERIC REGULATION. JRNL REF NAT.STRUCT.MOL.BIOL. V. 22 37 2015 JRNL REFN ESSN 1545-9985 JRNL PMID 25437913 JRNL DOI 10.1038/NSMB.2924 REMARK 2 REMARK 2 RESOLUTION. 2.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 14335 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 720 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2876 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2251 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2710 REMARK 3 BIN R VALUE (WORKING SET) : 0.2196 REMARK 3 BIN FREE R VALUE : 0.3122 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 166 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3978 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 79.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.52270 REMARK 3 B22 (A**2) : -8.90990 REMARK 3 B33 (A**2) : 3.38720 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.331 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.874 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4121 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5599 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1390 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 84 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 605 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4121 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 547 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4815 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.19 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.75 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4WO5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000204168. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14335 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.830 REMARK 200 RESOLUTION RANGE LOW (A) : 38.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 FOR THE DATA SET : 20.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3C4C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 0.2 M TRIMETHYLAMINE-N REMARK 280 -OXIDE, 20% (W/V) PEG-MME 2,000, PH 8.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.37400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 121.66900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.37400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 121.66900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 36.37400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 121.66900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 36.37400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 121.66900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 906 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 902 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 907 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 424 REMARK 465 GLY A 425 REMARK 465 SER A 426 REMARK 465 SER A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 HIS A 431 REMARK 465 HIS A 432 REMARK 465 HIS A 433 REMARK 465 SER A 434 REMARK 465 SER A 435 REMARK 465 GLY A 436 REMARK 465 GLU A 437 REMARK 465 THR A 438 REMARK 465 VAL A 439 REMARK 465 ARG A 440 REMARK 465 PHE A 441 REMARK 465 GLN A 442 REMARK 465 GLY A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 THR A 546 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 SER A 630 REMARK 465 SER A 722 REMARK 465 GLY A 723 REMARK 465 MET B 424 REMARK 465 GLY B 425 REMARK 465 SER B 426 REMARK 465 SER B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 HIS B 431 REMARK 465 HIS B 432 REMARK 465 HIS B 433 REMARK 465 SER B 434 REMARK 465 SER B 435 REMARK 465 GLY B 436 REMARK 465 GLU B 437 REMARK 465 THR B 438 REMARK 465 VAL B 439 REMARK 465 ARG B 440 REMARK 465 PHE B 441 REMARK 465 GLN B 442 REMARK 465 GLY B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ASP B 448 REMARK 465 ASP B 449 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 SER B 722 REMARK 465 GLY B 723 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 461 CD OE1 NE2 REMARK 470 LYS A 475 CG CD CE NZ REMARK 470 GLN A 493 CD OE1 NE2 REMARK 470 LYS A 499 CE NZ REMARK 470 LYS A 507 CG CD CE NZ REMARK 470 ARG A 509 CD NE CZ NH1 NH2 REMARK 470 LYS A 522 CG CD CE NZ REMARK 470 GLU A 533 CG CD OE1 OE2 REMARK 470 GLU A 545 CG CD OE1 OE2 REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 LYS A 551 CD CE NZ REMARK 470 ARG A 603 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 ASN A 631 CG OD1 ND2 REMARK 470 GLN A 653 CD OE1 NE2 REMARK 470 ASN A 658 CG OD1 ND2 REMARK 470 ARG A 662 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 680 CE NZ REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2 REMARK 470 SER A 683 OG REMARK 470 LYS A 687 CG CD CE NZ REMARK 470 LYS A 690 CD CE NZ REMARK 470 LYS A 698 CE NZ REMARK 470 LYS A 700 CG CD CE NZ REMARK 470 ARG A 719 NE CZ NH1 NH2 REMARK 470 LEU A 721 CG CD1 CD2 REMARK 470 GLN B 461 CD OE1 NE2 REMARK 470 ARG B 462 NE CZ NH1 NH2 REMARK 470 SER B 467 OG REMARK 470 LYS B 483 CE NZ REMARK 470 GLN B 493 CG CD OE1 NE2 REMARK 470 LYS B 499 CD CE NZ REMARK 470 ARG B 506 NE CZ NH1 NH2 REMARK 470 LYS B 507 CG CD CE NZ REMARK 470 ARG B 509 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 522 CG CD CE NZ REMARK 470 LYS B 547 CG CD CE NZ REMARK 470 GLU B 549 CG CD OE1 OE2 REMARK 470 LYS B 551 CG CD CE NZ REMARK 470 LYS B 552 CG CD CE NZ REMARK 470 GLU B 586 CG CD OE1 OE2 REMARK 470 GLN B 628 CG CD OE1 NE2 REMARK 470 ASP B 629 CG OD1 OD2 REMARK 470 SER B 630 OG REMARK 470 ASN B 660 CG OD1 ND2 REMARK 470 ARG B 662 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 664 CD OE1 NE2 REMARK 470 GLU B 667 CG CD OE1 OE2 REMARK 470 ARG B 671 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 680 CG CD CE NZ REMARK 470 LYS B 687 CG CD CE NZ REMARK 470 LYS B 690 CG CD CE NZ REMARK 470 ARG B 691 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 699 CG CD CE NZ REMARK 470 LYS B 700 CG CD CE NZ REMARK 470 GLU B 716 CG CD OE1 OE2 REMARK 470 LEU B 721 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 587 C - N - CA ANGL. DEV. = 22.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 468 -2.28 83.71 REMARK 500 ASN A 486 49.38 -78.78 REMARK 500 SER A 535 -152.97 55.94 REMARK 500 HIS A 540 -73.90 -73.50 REMARK 500 ARG A 575 -24.69 75.82 REMARK 500 ASP A 576 45.73 -140.66 REMARK 500 ASP A 587 -3.08 -1.98 REMARK 500 GLN A 612 22.55 -69.45 REMARK 500 SER A 616 -103.68 -154.69 REMARK 500 ILE A 617 -29.06 59.76 REMARK 500 TRP B 476 -72.84 -154.29 REMARK 500 HIS B 477 -75.37 -81.91 REMARK 500 ASN B 486 40.44 -76.61 REMARK 500 SER B 535 -162.02 59.73 REMARK 500 ALA B 543 35.38 -143.90 REMARK 500 ARG B 575 -19.90 87.46 REMARK 500 GLU B 586 49.20 -85.64 REMARK 500 ASP B 587 -2.30 -140.85 REMARK 500 ASP B 594 47.56 84.00 REMARK 500 LEU B 597 38.49 -140.78 REMARK 500 ASP B 629 30.42 -80.92 REMARK 500 SER B 630 -79.78 59.70 REMARK 500 LEU B 717 -8.48 -53.73 REMARK 500 ARG B 719 -88.64 66.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 324 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 324 B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3C4C RELATED DB: PDB REMARK 900 3C4C CONTAINS THE SAME PROTEIN COMPLEXED WITH THE SAME LIGAND. DBREF 4WO5 A 444 723 UNP P15056 BRAF_HUMAN 444 723 DBREF 4WO5 B 444 723 UNP P15056 BRAF_HUMAN 444 723 SEQADV 4WO5 MET A 424 UNP P15056 INITIATING METHIONINE SEQADV 4WO5 GLY A 425 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER A 426 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER A 427 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 431 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 432 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS A 433 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER A 434 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER A 435 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLY A 436 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLU A 437 UNP P15056 EXPRESSION TAG SEQADV 4WO5 THR A 438 UNP P15056 EXPRESSION TAG SEQADV 4WO5 VAL A 439 UNP P15056 EXPRESSION TAG SEQADV 4WO5 ARG A 440 UNP P15056 EXPRESSION TAG SEQADV 4WO5 PHE A 441 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLN A 442 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLY A 443 UNP P15056 EXPRESSION TAG SEQADV 4WO5 ALA A 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 4WO5 SER A 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 4WO5 LYS A 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 4WO5 ARG A 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 4WO5 ASN A 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 4WO5 SER A 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 4WO5 GLU A 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 4WO5 SER A 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 4WO5 ARG A 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 4WO5 SER A 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 4WO5 ARG A 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 4WO5 GLU A 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 4WO5 GLU A 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 4WO5 GLU A 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 4WO5 SER A 722 UNP P15056 PRO 722 ENGINEERED MUTATION SEQADV 4WO5 GLY A 723 UNP P15056 LYS 723 ENGINEERED MUTATION SEQADV 4WO5 MET B 424 UNP P15056 INITIATING METHIONINE SEQADV 4WO5 GLY B 425 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER B 426 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER B 427 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 430 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 431 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 432 UNP P15056 EXPRESSION TAG SEQADV 4WO5 HIS B 433 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER B 434 UNP P15056 EXPRESSION TAG SEQADV 4WO5 SER B 435 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLY B 436 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLU B 437 UNP P15056 EXPRESSION TAG SEQADV 4WO5 THR B 438 UNP P15056 EXPRESSION TAG SEQADV 4WO5 VAL B 439 UNP P15056 EXPRESSION TAG SEQADV 4WO5 ARG B 440 UNP P15056 EXPRESSION TAG SEQADV 4WO5 PHE B 441 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLN B 442 UNP P15056 EXPRESSION TAG SEQADV 4WO5 GLY B 443 UNP P15056 EXPRESSION TAG SEQADV 4WO5 ALA B 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 4WO5 SER B 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 4WO5 LYS B 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 4WO5 ARG B 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 4WO5 ASN B 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 4WO5 SER B 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 4WO5 GLU B 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 4WO5 SER B 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 4WO5 ARG B 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 4WO5 SER B 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 4WO5 ARG B 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 4WO5 GLU B 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 4WO5 GLU B 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 4WO5 GLU B 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 4WO5 SER B 722 UNP P15056 PRO 722 ENGINEERED MUTATION SEQADV 4WO5 GLY B 723 UNP P15056 LYS 723 ENGINEERED MUTATION SEQRES 1 A 300 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 300 GLU THR VAL ARG PHE GLN GLY ARG ASP SER SER ASP ASP SEQRES 3 A 300 TRP GLU ILE PRO ASP GLY GLN ILE THR VAL GLY GLN ARG SEQRES 4 A 300 ILE GLY SER GLY SER PHE GLY THR VAL TYR LYS GLY LYS SEQRES 5 A 300 TRP HIS GLY ASP VAL ALA VAL LYS MET LEU ASN VAL THR SEQRES 6 A 300 ALA PRO THR PRO GLN GLN LEU GLN ALA PHE LYS ASN GLU SEQRES 7 A 300 VAL GLY VAL LEU ARG LYS THR ARG HIS VAL ASN ILE LEU SEQRES 8 A 300 LEU PHE MET GLY TYR SER THR LYS PRO GLN LEU ALA ILE SEQRES 9 A 300 VAL THR GLN TRP CYS GLU GLY SER SER LEU TYR HIS HIS SEQRES 10 A 300 LEU HIS ALA SER GLU THR LYS PHE GLU MET LYS LYS LEU SEQRES 11 A 300 ILE ASP ILE ALA ARG GLN THR ALA ARG GLY MET ASP TYR SEQRES 12 A 300 LEU HIS ALA LYS SER ILE ILE HIS ARG ASP LEU LYS SER SEQRES 13 A 300 ASN ASN ILE PHE LEU HIS GLU ASP ASN THR VAL LYS ILE SEQRES 14 A 300 GLY ASP PHE GLY LEU ALA THR VAL LYS SER ARG TRP SER SEQRES 15 A 300 GLY SER HIS GLN PHE GLU GLN LEU SER GLY SER ILE LEU SEQRES 16 A 300 TRP MET ALA PRO GLU VAL ILE ARG MET GLN ASP SER ASN SEQRES 17 A 300 PRO TYR SER PHE GLN SER ASP VAL TYR ALA PHE GLY ILE SEQRES 18 A 300 VAL LEU TYR GLU LEU MET THR GLY GLN LEU PRO TYR SER SEQRES 19 A 300 ASN ILE ASN ASN ARG ASP GLN ILE ILE GLU MET VAL GLY SEQRES 20 A 300 ARG GLY SER LEU SER PRO ASP LEU SER LYS VAL ARG SER SEQRES 21 A 300 ASN CYS PRO LYS ARG MET LYS ARG LEU MET ALA GLU CYS SEQRES 22 A 300 LEU LYS LYS LYS ARG ASP GLU ARG PRO SER PHE PRO ARG SEQRES 23 A 300 ILE LEU ALA GLU ILE GLU GLU LEU ALA ARG GLU LEU SER SEQRES 24 A 300 GLY SEQRES 1 B 300 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 300 GLU THR VAL ARG PHE GLN GLY ARG ASP SER SER ASP ASP SEQRES 3 B 300 TRP GLU ILE PRO ASP GLY GLN ILE THR VAL GLY GLN ARG SEQRES 4 B 300 ILE GLY SER GLY SER PHE GLY THR VAL TYR LYS GLY LYS SEQRES 5 B 300 TRP HIS GLY ASP VAL ALA VAL LYS MET LEU ASN VAL THR SEQRES 6 B 300 ALA PRO THR PRO GLN GLN LEU GLN ALA PHE LYS ASN GLU SEQRES 7 B 300 VAL GLY VAL LEU ARG LYS THR ARG HIS VAL ASN ILE LEU SEQRES 8 B 300 LEU PHE MET GLY TYR SER THR LYS PRO GLN LEU ALA ILE SEQRES 9 B 300 VAL THR GLN TRP CYS GLU GLY SER SER LEU TYR HIS HIS SEQRES 10 B 300 LEU HIS ALA SER GLU THR LYS PHE GLU MET LYS LYS LEU SEQRES 11 B 300 ILE ASP ILE ALA ARG GLN THR ALA ARG GLY MET ASP TYR SEQRES 12 B 300 LEU HIS ALA LYS SER ILE ILE HIS ARG ASP LEU LYS SER SEQRES 13 B 300 ASN ASN ILE PHE LEU HIS GLU ASP ASN THR VAL LYS ILE SEQRES 14 B 300 GLY ASP PHE GLY LEU ALA THR VAL LYS SER ARG TRP SER SEQRES 15 B 300 GLY SER HIS GLN PHE GLU GLN LEU SER GLY SER ILE LEU SEQRES 16 B 300 TRP MET ALA PRO GLU VAL ILE ARG MET GLN ASP SER ASN SEQRES 17 B 300 PRO TYR SER PHE GLN SER ASP VAL TYR ALA PHE GLY ILE SEQRES 18 B 300 VAL LEU TYR GLU LEU MET THR GLY GLN LEU PRO TYR SER SEQRES 19 B 300 ASN ILE ASN ASN ARG ASP GLN ILE ILE GLU MET VAL GLY SEQRES 20 B 300 ARG GLY SER LEU SER PRO ASP LEU SER LYS VAL ARG SER SEQRES 21 B 300 ASN CYS PRO LYS ARG MET LYS ARG LEU MET ALA GLU CYS SEQRES 22 B 300 LEU LYS LYS LYS ARG ASP GLU ARG PRO SER PHE PRO ARG SEQRES 23 B 300 ILE LEU ALA GLU ILE GLU GLU LEU ALA ARG GLU LEU SER SEQRES 24 B 300 GLY HET 324 A 801 27 HET 324 B 801 27 HETNAM 324 N-{3-[(5-CHLORO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL) HETNAM 2 324 CARBONYL]-2,4-DIFLUOROPHENYL}PROPANE-1-SULFONAMIDE FORMUL 3 324 2(C17 H14 CL F2 N3 O3 S) FORMUL 5 HOH *77(H2 O) HELIX 1 AA1 THR A 491 ARG A 506 1 16 HELIX 2 AA2 SER A 536 ALA A 543 1 8 HELIX 3 AA3 GLU A 549 LYS A 570 1 22 HELIX 4 AA4 LEU A 597 TRP A 604 1 8 HELIX 5 AA5 PHE A 610 SER A 614 5 5 HELIX 6 AA6 ALA A 621 ARG A 626 1 6 HELIX 7 AA7 SER A 634 GLY A 652 1 19 HELIX 8 AA8 ARG A 662 ARG A 671 1 10 HELIX 9 AA9 ASP A 677 VAL A 681 5 5 HELIX 10 AB1 PRO A 686 LEU A 697 1 12 HELIX 11 AB2 LYS A 700 ARG A 704 5 5 HELIX 12 AB3 SER A 706 ALA A 718 1 13 HELIX 13 AB4 THR B 491 THR B 508 1 18 HELIX 14 AB5 SER B 536 ALA B 543 1 8 HELIX 15 AB6 GLU B 549 LYS B 570 1 22 HELIX 16 AB7 SER B 616 MET B 620 5 5 HELIX 17 AB8 ALA B 621 ARG B 626 1 6 HELIX 18 AB9 SER B 634 GLY B 652 1 19 HELIX 19 AC1 ASN B 661 ARG B 671 1 11 HELIX 20 AC2 ASP B 677 VAL B 681 5 5 HELIX 21 AC3 PRO B 686 LEU B 697 1 12 HELIX 22 AC4 LYS B 700 ARG B 704 5 5 HELIX 23 AC5 SER B 706 LEU B 717 1 12 SHEET 1 AA1 5 ARG A 462 GLY A 464 0 SHEET 2 AA1 5 GLY A 469 LYS A 475 -1 O VAL A 471 N ILE A 463 SHEET 3 AA1 5 ASP A 479 LEU A 485 -1 O MET A 484 N THR A 470 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N MET A 517 O VAL A 528 SHEET 1 AA2 2 ILE A 582 HIS A 585 0 SHEET 2 AA2 2 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 AA3 5 THR B 458 SER B 465 0 SHEET 2 AA3 5 GLY B 469 LYS B 475 -1 O VAL B 471 N GLY B 464 SHEET 3 AA3 5 ASP B 479 LEU B 485 -1 O MET B 484 N THR B 470 SHEET 4 AA3 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 AA3 5 PHE B 516 SER B 520 -1 N MET B 517 O VAL B 528 SHEET 1 AA4 2 ILE B 582 LEU B 584 0 SHEET 2 AA4 2 VAL B 590 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 LYS A 522 PRO A 523 0 -1.58 CISPEP 2 ALA A 543 SER A 544 0 -3.23 CISPEP 3 GLU A 586 ASP A 587 0 17.12 CISPEP 4 SER A 614 GLY A 615 0 6.92 CISPEP 5 ASN A 631 PRO A 632 0 -2.41 CISPEP 6 ARG A 719 GLU A 720 0 -4.28 CISPEP 7 SER B 467 PHE B 468 0 0.50 CISPEP 8 HIS B 477 GLY B 478 0 -0.64 CISPEP 9 ASP B 587 ASN B 588 0 -5.52 CISPEP 10 GLY B 596 LEU B 597 0 7.81 CISPEP 11 ALA B 718 ARG B 719 0 4.49 SITE 1 AC1 17 ILE A 463 VAL A 471 ALA A 481 VAL A 482 SITE 2 AC1 17 LYS A 483 LEU A 505 LEU A 514 THR A 529 SITE 3 AC1 17 GLN A 530 TRP A 531 CYS A 532 SER A 535 SITE 4 AC1 17 PHE A 583 GLY A 593 ASP A 594 PHE A 595 SITE 5 AC1 17 GLY A 596 SITE 1 AC2 13 VAL B 471 ALA B 481 VAL B 482 LYS B 483 SITE 2 AC2 13 LEU B 514 THR B 529 GLN B 530 TRP B 531 SITE 3 AC2 13 CYS B 532 PHE B 583 ASP B 594 PHE B 595 SITE 4 AC2 13 HOH B 911 CRYST1 65.610 72.748 243.338 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015242 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013746 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004110 0.00000